Researchers at the MD Anderson Cancer Center at the University of Texas have shown that COVID-19 mRNA vaccines may increase the survival rate in certain cancer patients. (Jason Fochtman/Houston Chronicle via Getty Images) Houston Chronicle via Getty Images

Certain individuals with cancer were significantly more likely to survive if they received a COVID-19 mRNA vaccine, according to researchers at the University of Texas MD Anderson Cancer Center . This result was seen specifically in patients being treated with immune checkpoint inhibitors, a form of immunotherapy. The improvement was independent of the vaccine manufacturer or number of doses that the patients received. Based on these results, the researchers currently are designing a randomized phase III clinical trial to determin

See Full Page